Deloitte April 22, 2024

Accounting for ethical GenAI development, deployments, and monitoring in health care and medicine

The health care industry thrives on trust

The health care industry thrives on trust— trust in providers and payers, medicines and therapies, supply chains, and all the technologies that enable enterprise operations and delivery of care.

Many business leaders likely know well the sobering examples of health care AI deployments that introduced risks effecting enterprise trustworthiness and even health equity.

With the arrival of a new kind of AI—Generative AI—the stakes are even higher, and health care leaders are appropriately concerned about the risks this type of AI could create. Already, 75% of leading health care companies are experimenting with Generative AI or attempting to scale...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Insurance, Payer, Pharma, Pharma / Biotech, Provider, Survey / Study, Technology, Trends
UK sets out position on regulating AI as a medical device
How AI can accelerate prior and concurrent authorization processes
Profluent releases AI-enabled OpenCRISPR-1 to edit the human genome
Large Language Models Show Promise for Streamlining Physician Workflows, But Safety Concerns Remain
AI engineers report burnout and rushed rollouts as 'rat race' to stay competitive hits tech industry

Share This Article